GI Flashcards
Cimetidine, Ranitidine, Famotidine, Nizatidine (MOA)
Reversible H2 receptor blockers -> decreased secretion by parietal cells
Cimetidine, Ranitidine, Famotidine, Nizatidine (CU)
Peptic ulcer, gastritis, mild esophageal reflux
Cimetidine, Ranitidine, Famotidine, Nizatidine (T)
Cimetidine is a potent inhibitor of city P450 (multiple drug interactions) it also has antiangregenic effects (prolactin release, gynocomastia, impotence, decreased libido in males); can cross BBB (confusion, dizziness, HA) and placenta. Both cimetidine and ranitidine decrease renal excretion of creatinine. Other H2 blockers are relatively free of these effects.
Omeprazole. Lansoprazole (MOA)
Irreversibly inhibit H+/K+ ATPase in stoamch parietal cells
Omeprazole. Lansoprazole (CU)
Peptic ulcer, gastritis, esophageal reflux, Z-E syndrome
Omeprazole. Lansoprazole (T)
Increased risk of C. diff infection, pneumonia. Hip fractures, decreased serum Mg with long term use.
Bismuth, sucralfate (MOA)
Bind to ulcer base, providing physical protection and allowing bicarb secretion to reestablish pH gradient in the mucous layer
Bismuth, sucralfate (CU)
Increased ulcer healing, travelers’ diarrhea
Misoprostol (MOA)
PGE1 analog. Increased production and secretion of gastric mucous barrier, decreased acid production
Misoprostol (CU)
Prevention of NSAID-induced peptic ulcer; maintenance of a PDA. Also used to induce labor (ripens cervix)
Octreotide (MOA)
Long-acting somatostatin analog
Octreotide (CU)
Acute variceal bleeds, acromegaly, VIPoma, and carcinoid tumors
Octreotide (T)
Nausea, cramps, steatorrhea
Misoprostol (T)
Diarrhea, Contraindicated in women of childbearing potential (abortifacient).
Aluminum hydroxide
Antacid. Hypokalemia. Constipation and hypophosphatemia: proximal muscle weakness, osteodystrophy, seizures